#ARCC2020 – the 2020 ARCC Conference

Cancellation of the 2020 ARCC Conference

Every year, we look forward to connecting with the ARCC Network in person at our annual conference. But, given the growing concerns around COVID-19, we have made the difficult decision to cancel our in-person conference, scheduled to be held in Saskatoon from May 25^th-26^th, 2020.

We are very disappointed, the ARCC conference is an incredibly important event for us, and we all benefit by gathering in person to learn, share, and network. We believe this decision was unavoidable, and the right decision to make.

We will share more information as it becomes available, so please watch for emails from arcc@cc-arcc.ca and keep an eye on this page. Please email Rebecca.Mercer@cancercare.on.ca if you have any specific questions.

Abstract/Presentation Information

Abstract submission for ARCC2020 is NOW CLOSED. Submitters will be notified by the end of March 2020 regarding presentation status.

View the 2020 ARCC Conference Abstract Guidelines here

Questions? Contact us at arcc@cancercare.on.ca

Student & New Professional Travel Awards

ARCC will again be offering travel support (up to $1000) for students presenting at our conference. For the 2020 ARCC Conference, we will also have some funding available for new professional (defined as someone completing their final degree within the past 5 years). To be eligible for a travel award, the student or new professional must be submitting an abstract to and presenting at the ARCC2020. The application for student and new professional travel awards is electronic and will only be available in parallel with abstract submission. If you have any questions, please contact ARCC@cancercare.on.ca

To Apply: The application for Student & New Professional Travel Awards will open alongside abstract submission on December 6th, 2019.

Guidelines for Travel awards can be found within the ARCC2020 Abstract Guidelines

contact ARCC@cancercare.on.ca for more information

Registration

The 2020 ARCC Conference has been cancelled. Registration is no longer available. Refunds will be automatically processed if you have already registered for the conference.

Early-bird rates are in effect until April 17, 2020

Member – $150

Non-Member – $250

Student (member) – $75

Student (non-member) – $100

New-Professional** (members only) – $100

Industry – $600

**If you are a new professional (within 5 years of receiving your terminal degree) please email Rebecca.Mercer@cancercare.on.ca with your graduation details to be eligible for a special registration code providing this discounted rate!!!

**If you are a patient looking to attend the 2020 ARCC Conference, please email Rebecca.Mercer@cancercare.on.ca regarding complementary registration availability

Hotel & Flight Info

The 2020 ARCC Conference has been cancelled.

The Canadian Centre for Applied Research in Cancer Control (ARCC) is pleased to announce that its 9th annual conference, ARCC2020, will take place from May 25th to 26th at TCU Place in Saskatoon, Saskatchewan. The objective of this conference is to bridge a connection between researchers and decision-makers, using health economics, services, policy and ethics research to improve cancer control and the delivery of cancer care.

ARCC2020 – the 2020 ARCC Conference
Canada’s Applied Research in Cancer Control Conference

May 25-26, 2020

Venue:
TCU Place Saskatoon
35 22 St E

Saskatoon, SK

Maps were disabled by the visitor on this site.

Invited Speakers

Natalie Coburn MD MPH

Dr. Coburn is a surgical oncologist at Sunnybrook’s Odette Cancer Center, and Professor of Surgery at the University of Toronto, with a clinical practice completely devoted to Hepato-Pancreatico-Biliary and upper Gastrointestinal cancers. She has been on staff at the Odette Cancer Centre since 2004, and has served in many leadership roles including head of the division of general surgery, chief examiner for the Royal College of Physicians and Surgeons of Canada’s surgical oncology fellowship examination, and the Clinical Lead in Patient-Reported Outcomes and Symptom Management at Ontario Health Cancer Care Ontario. She now holds the Sherif and Mary-Lou Hanna Chair in Surgical Oncology Research.

Dr. Coburn’s research is focused on evaluating and improving the outcomes for patients who have gastrointestinal tract cancers. The major techniques utilized in her research are assessment of outcomes through examination of administrative databases, such as those at the Institute of Clinical Evaluative Sciences (ICES) and the Surveillance Epidemiology and End Results (SEER) database in the United States. Following evaluation of patient outcomes, she has engaged knowledge translation researchers to examine the gaps in physician knowledge that result in gaps in patient care, so that the quality of patient care can be improved by providing physicians with training to reduce the gaps in their knowledge.

Colleen Cuthbert PhD

Coming Soon!

Claire de Oliveira PhD

Claire de Oliveira is a Reader in Health Economics at the Centre for Health Economics and the Hull York Medical School at the University of York. In addition, she is the Expert Lead in cancer economics at the Canadian Partnership Against Cancer, Health Economist at the Centre for Addiction and Mental Health (CAMH) in Toronto, Ontario, an Associate Professor (status only) at the Institute of Health Policy, Management and Evaluation at the University of Toronto, and an Adjunct Scientist at ICES. Her main areas of cancer-related research include the development of costing methodology, the use of administrative health care data to quantify the economic burden of cancer, and the assessment of value for money in cancer care.

Dr. de Oliveira holds memberships with the Canadian Centre for Applied Research in Cancer Control, where she is one of the program leads for Health Technology Assessment, and the International Health Economics Association, where is a board member. She is also a collaborator at the Toronto Health Economics Technology Assessment Collaborative.

Patti Groome PhD

Patti Groome is a Professor in the Department of Public Health Sciences at Queen’s University in Kingston, Canada and a Senior Scientist in the Division of Cancer Care and Epidemiology at the Queen’s Cancer Research Institute. She was the founding Director of the ICES Queen’s Health Services Research Facility. Her research involves the delivery of health services to persons with cancer most recently with a focus on the problem of a late cancer diagnosis. She studies diagnostic pathways and the problem of long diagnostic intervals and its predictors. Dr. Groome is also involved in other administrative data-based studies of cancer care quality and access within Ontario and across Canada, with questions relating to the interface between primary and cancer care, the impact of practice variations on control of disease and the role of comorbid illnesses on treatment and outcome. In the past, she conducted Ontario-wide retrospective chart reviews of practice patterns and outcome in laryngeal cancer, prostate cancer and oral cavity cancer. Dr. Groome’s research has been funded by the Canadian Institutes of Health Research, the Canadian Cancer Society, the Canadian Foundation for Innovation, the Ontario Innovation Trust and the OICR/CCO Health Services Research Program.

Terry Hawrysh

Coming Soon!

Malcolm King PhD

Dr. Malcolm King, a member of the Mississaugas of the New Credit First Nation, is a health researcher at the University of Saskatchewan, joining the Department of Community Health & Epidemiology in October 2017. There, he serves as the Scientific Director of SCPOR, the Saskatchewan Centre for Patient-Oriented Research; he also continues to teach and research in Indigenous health, with a particular focus on wellness and engagement.

From 2009 to 2016, Dr. King led the CIHR Institute of Aboriginal Peoples’ Health as its Scientific Director, spearheading the development of a national health research agenda aimed at improving wellness and achieving health equity for First Nations People, Métis and Inuit in Canada.

Dr. King’s international Indigenous health interests include improving Indigenous health through workforce development and provision of culturally appropriate care, and developing Indigenous health indicators to monitor progress in programs aimed at achieving wellness and health equity.

Dr. King was honoured with a National Aboriginal Achievement Award in 1999, and in 2016 he was named a Fellow of the Canadian Academy of Health Sciences.

John McLaughlin PhD

Coming Soon!

Dean Regier PhD

Coming Soon!

Stay tuned for speakers and information!

Conference Committee

Dr. Kelvin Chan, MD, FRCP, MSc, PhD - (ARCC Co-Director)

Dr Kelvin Chan is a Medical Oncologist at the Sunnybrook Odette Cancer Centre, an Associate Professor at the University of Toronto, and an associate scientist at the Sunnybrook Research Institute. He specializes in GI oncology and Head and Neck oncology. He has recently completed his PhD in Biostatistics (focusing on statistical methods in health economic evaluations) at the Dalla Lana School of Public Health, University of Toronto.

As a clinical epidemiologist and biostatistician, Dr. Chan’s research interests include health services research, health technology assessment, meta-analysis including network meta-analysis, cost-effectiveness analyses, and statistical methods research in health economics. He is the Co-Director at the Canadian Centre for Applied Research in Cancer Control (ARCC), funded by the Canadian Cancer Society (CCS).

Professionally, Dr Chan has an interest in cancer drug reimbursement related issues. He is a member of multiple provincial and national committees related to cancer drug assessments and recommendations including membership at the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), the Committee to Evaluate Drug (CED) and the Interim Chair for the Ontario Steering Committee of Cancer Drugs (OSCCD), Ontario MOHLTC and Cancer Care Ontario. He is also the Clinical Lead for the Provincial Drug Reimbursement Programs (PDRP) at Cancer Care Ontario (CCO).

Dr. Stuart Peacock, PhD - (ARCC Co-Director)

Stuart Peacock holds the Leslie Diamond Chair in Cancer Survivorship and is a Professor in the Faculty of Health Sciences, Simon Fraser University. He is currently Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC is a pan-Canadian research centre providing interdisciplinary leadership in health economics, services, policy and ethics research. Stuart is also a Distinguished Scientist in Cancer Control Research at the BC Cancer Agency, a member of the Board of Directors of the Canadian Agency for Drugs and Technologies in Health, and past President of the International Society on Priorities in Health Care. He has held university positions in Canada, Australia and the UK. Over the past 20 years, Stuart’s main research interests have focused on research into developing more effective cancer services, making health system funding decisions fairer and more transparent, and improving the quality of life of cancer patients and survivors.

Mr. Riaz Alvi

Riaz Alvi is the Director – Epidemiology & Performance Management with the Saskatchewan Cancer Agency.

Dr. Winson Cheung

Winson Y. Cheung, MD, MPH, FRCPC is a medical oncologist and a nationally and internationally recognized health services researcher and real-world data scientist. He is currently appointed as Full Professor in the Departments of Oncology, Medicine, and Community Health Sciences at the University of Calgary where he is also the Provincial Director and Chair of Cancer Health Services Research and Real-World Evidence. Prior to his leadership recruitment to Calgary in 2017, he worked at BC Cancer in Vancouver for 7 years. Dr. Cheung’s primary research interest is using big data for health services and outcomes research as well as generating real-world evidence across all tumor sites. His projects focus on understanding the interplay of various patient, physician, and system level factors that drive practice patterns in the population-based setting and learning how costs and processes can be modified to better inform care. The overarching goal of his work is to ensure that cancer care is appropriately accessed and delivered to patients in an equitable and effective manner. His own research and those of his trainees appear frequently in high impact scientific journals. To date, he has published more than 200 peer-reviewed manuscripts.

Ms. Carole McMahon

Information coming soon!

#ARCC2020 – the 2020 ARCC Conference

Invited Speakers

Conference Committee

Recent Projects

Login

RECENT POSTS

Login Status

#ARCC2020 – the 2020 ARCC Conference

Invited Speakers

Conference Committee

Recent Projects

Login

Connect With Us!

RECENT POSTS

Login Status